Patents by Inventor Houman David Hemmati

Houman David Hemmati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING OCULAR INFLAMMATORY DISEASES
    Publication number: 20250195489
    Abstract: The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity relative to existing immunomodulatory, immunosuppressant, or non-steroidal anti-inflammatory therapies, including corticosteroids and antihistamines, while also providing an improved safety and convenience profile relative to one or both agents.
    Type: Application
    Filed: March 6, 2025
    Publication date: June 19, 2025
    Applicant: Iolyx Therapeutics, Inc.
    Inventors: Elizabeth W. Jeffords, Hovhannes John Gukasyan, Rozemarijn Verhoeven, Houman David Hemmati, Daniel J. Estes, Richard GRAHAM
  • Methods of treating ocular inflammatory diseases
    Patent number: 12263160
    Abstract: The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity relative to existing immunomodulatory, immunosuppressant, or non-steroidal anti-inflammatory therapies, including corticosteroids and antihistamines, while also providing an improved safety and convenience profile relative to one or both agents.
    Type: Grant
    Filed: September 22, 2022
    Date of Patent: April 1, 2025
    Assignee: IOLYX THERAPEUTICS, INC.
    Inventors: Elizabeth W. Jeffords, Hovhannes John Gukasyan, Rozemarijn Verhoeven, Houman David Hemmati, Daniel J. Estes, Richard Graham
  • METHODS OF TREATING OCULAR INFLAMMATORY DISEASES
    Publication number: 20230090417
    Abstract: The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity relative to existing immunomodulatory, immunosuppressant, or non-steroidal anti-inflammatory therapies, including corticosteroids and antihistamines, while also providing an improved safety and convenience profile relative to one or both agents.
    Type: Application
    Filed: September 22, 2022
    Publication date: March 23, 2023
    Applicant: Iolyx Therapeutics, Inc.
    Inventors: Elizabeth W. Jeffords, Hovhannes John Gukasyan, Rozemarijn Verhoeven, Houman David Hemmati, Daniel J. Estes